Indigenous Td Vaccine: Nadda Launches CRI Kasauli Jab
Why in the news
Health Minister J.P. Nadda launched a home-grown Td vaccine, seen as a step towards self-reliance in vaccines and a stronger public health system.
Key facts
- Product: Tetanus and Adult Diphtheria (Td) vaccine, indigenously manufactured.
- Manufacturer: Central Research Institute (CRI), Kasauli.
- Use: supplied through the Universal Immunization Programme (UIP).
- Supply: 55 lakh doses by April 2026; production to grow over the coming years.
| Body | Key points |
|---|---|
| Universal Immunization Programme | Among the largest immunisation programmes worldwide; 11 vaccines against 12 diseases; run by the Government of India to lower child and maternal mortality |
| CRI, Kasauli | Government vaccine maker; first government facility to make vaccines under Good Manufacturing Practices (GMP); important in public sector vaccine output |
Exam angle
- Maker of the Td vaccine: CRI Kasauli.
- UIP numbers: 11 vaccines, 12 diseases.
- First government unit producing vaccines under GMP: CRI Kasauli.